[Periprosthetic infections following total hip replacement with ESBL-forming bacteria: importance for clinical...

Area of Science:

• Orthopedic Surgery
• Infectious Diseases
• Microbiology

Context:

• Implant-associated infections are severe complications following total hip replacement, with higher rates after revision surgery.
• The increasing prevalence of multidrug-resistant bacteria in hospital settings poses a significant threat to patients with artificial joints.
• Enterobacteria producing extended spectrum beta-lactamases (ESBL) are a major group of multidrug-resistant pathogens, particularly relevant in intensive care units.

Purpose:

• To provide an overview of the epidemiology and diagnostics of ESBL-expressing bacteria in orthopedic and trauma surgery.
• To highlight the challenges in managing implant-associated infections caused by these resistant bacteria.
• To emphasize the growing importance of ESBL-producing bacteria as pathogens in orthopedic settings, necessitating specialized precautions and treatment strategies.

Summary:

• Extended spectrum beta-lactamases (ESBLs) are enzymes conferring resistance to cephalosporins, making ESBL-producing bacteria a significant concern.
• ESBL-producing bacteria, though well-known in intensive care, are increasingly identified as pathogens in orthopedic and trauma surgery.
• Managing implant infections caused by ESBL-positive bacteria presents unique difficulties, underscoring the need for heightened awareness and specific management protocols.

Impact:

• Recognizing ESBL-producing bacteria as increasingly important pathogens in orthopedic and trauma surgery is crucial.
• Specialized precautions and tailored treatment approaches are required for implant-associated infections involving ESBL-positive bacteria.
• This study underscores that ESBLs are no longer a rare phenomenon in orthopedic and trauma surgery, impacting patient outcomes and requiring updated clinical guidelines.